Report Detail
Global Implantable Neuromodulation Device Market Growth 2022-2028
- RnM4474619 |
- 29 July, 2022 |
- Global |
- 107 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
The global market for Implantable Neuromodulation Device is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Implantable Neuromodulation Device market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Implantable Neuromodulation Device players cover Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical and Synapse Biomedical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Implantable Neuromodulation Device market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Implantable Neuromodulation Device market, with both quantitative and qualitative data, to help readers understand how the Implantable Neuromodulation Device market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Implantable Neuromodulation Device market and forecasts the market size by Type (Spinal Cord Stimulation, Deep Brain Stimulation and Gastric Stimulation), by Application (Parkinson's Disease, Epilepsy, Pain and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Spinal Cord Stimulation
Deep Brain Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segmentation by application
Parkinson's Disease
Epilepsy
Pain
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Chapter Introduction
Chapter 1: Scope of Implantable Neuromodulation Device, Research Methodology, etc.
Chapter 2: Executive Summary, global Implantable Neuromodulation Device market size (sales and revenue) and CAGR, Implantable Neuromodulation Device market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Implantable Neuromodulation Device sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Implantable Neuromodulation Device sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Implantable Neuromodulation Device market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics and Autonomic Technologies, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Implantable Neuromodulation Device Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Implantable Neuromodulation Device by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Implantable Neuromodulation Device by Country/Region, 2017, 2022 & 2028
- 2.2 Implantable Neuromodulation Device Segment by Type
- 2.2.1 Spinal Cord Stimulation
- 2.2.2 Deep Brain Stimulation
- 2.2.3 Gastric Stimulation
- 2.2.4 Transcranial Magnetic Stimulation
- 2.2.5 Transcutaneous Electrical Stimulation
- 2.2.6 Other
- 2.3 Implantable Neuromodulation Device Sales by Type
- 2.3.1 Global Implantable Neuromodulation Device Sales Market Share by Type (2017-2022)
- 2.3.2 Global Implantable Neuromodulation Device Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Implantable Neuromodulation Device Sale Price by Type (2017-2022)
- 2.4 Implantable Neuromodulation Device Segment by Application
- 2.4.1 Parkinson's Disease
- 2.4.2 Epilepsy
- 2.4.3 Pain
- 2.4.4 Other
- 2.5 Implantable Neuromodulation Device Sales by Application
- 2.5.1 Global Implantable Neuromodulation Device Sale Market Share by Application (2017-2022)
- 2.5.2 Global Implantable Neuromodulation Device Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Implantable Neuromodulation Device Sale Price by Application (2017-2022)
3 Global Implantable Neuromodulation Device by Company
- 3.1 Global Implantable Neuromodulation Device Breakdown Data by Company
- 3.1.1 Global Implantable Neuromodulation Device Annual Sales by Company (2020-2022)
- 3.1.2 Global Implantable Neuromodulation Device Sales Market Share by Company (2020-2022)
- 3.2 Global Implantable Neuromodulation Device Annual Revenue by Company (2020-2022)
- 3.2.1 Global Implantable Neuromodulation Device Revenue by Company (2020-2022)
- 3.2.2 Global Implantable Neuromodulation Device Revenue Market Share by Company (2020-2022)
- 3.3 Global Implantable Neuromodulation Device Sale Price by Company
- 3.4 Key Manufacturers Implantable Neuromodulation Device Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Implantable Neuromodulation Device Product Location Distribution
- 3.4.2 Players Implantable Neuromodulation Device Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Implantable Neuromodulation Device by Geographic Region
- 4.1 World Historic Implantable Neuromodulation Device Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Implantable Neuromodulation Device Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Implantable Neuromodulation Device Annual Revenue by Geographic Region
- 4.2 World Historic Implantable Neuromodulation Device Market Size by Country/Region (2017-2022)
- 4.2.1 Global Implantable Neuromodulation Device Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Implantable Neuromodulation Device Annual Revenue by Country/Region
- 4.3 Americas Implantable Neuromodulation Device Sales Growth
- 4.4 APAC Implantable Neuromodulation Device Sales Growth
- 4.5 Europe Implantable Neuromodulation Device Sales Growth
- 4.6 Middle East & Africa Implantable Neuromodulation Device Sales Growth
5 Americas
- 5.1 Americas Implantable Neuromodulation Device Sales by Country
- 5.1.1 Americas Implantable Neuromodulation Device Sales by Country (2017-2022)
- 5.1.2 Americas Implantable Neuromodulation Device Revenue by Country (2017-2022)
- 5.2 Americas Implantable Neuromodulation Device Sales by Type
- 5.3 Americas Implantable Neuromodulation Device Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Implantable Neuromodulation Device Sales by Region
- 6.1.1 APAC Implantable Neuromodulation Device Sales by Region (2017-2022)
- 6.1.2 APAC Implantable Neuromodulation Device Revenue by Region (2017-2022)
- 6.2 APAC Implantable Neuromodulation Device Sales by Type
- 6.3 APAC Implantable Neuromodulation Device Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Implantable Neuromodulation Device by Country
- 7.1.1 Europe Implantable Neuromodulation Device Sales by Country (2017-2022)
- 7.1.2 Europe Implantable Neuromodulation Device Revenue by Country (2017-2022)
- 7.2 Europe Implantable Neuromodulation Device Sales by Type
- 7.3 Europe Implantable Neuromodulation Device Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Implantable Neuromodulation Device by Country
- 8.1.1 Middle East & Africa Implantable Neuromodulation Device Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Implantable Neuromodulation Device Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Implantable Neuromodulation Device Sales by Type
- 8.3 Middle East & Africa Implantable Neuromodulation Device Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Implantable Neuromodulation Device
- 10.3 Manufacturing Process Analysis of Implantable Neuromodulation Device
- 10.4 Industry Chain Structure of Implantable Neuromodulation Device
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Implantable Neuromodulation Device Distributors
- 11.3 Implantable Neuromodulation Device Customer
12 World Forecast Review for Implantable Neuromodulation Device by Geographic Region
- 12.1 Global Implantable Neuromodulation Device Market Size Forecast by Region
- 12.1.1 Global Implantable Neuromodulation Device Forecast by Region (2023-2028)
- 12.1.2 Global Implantable Neuromodulation Device Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Implantable Neuromodulation Device Forecast by Type
- 12.7 Global Implantable Neuromodulation Device Forecast by Application
13 Key Players Analysis
- 13.1 Medtronic
- 13.1.1 Medtronic Company Information
- 13.1.2 Medtronic Implantable Neuromodulation Device Product Offered
- 13.1.3 Medtronic Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Medtronic Main Business Overview
- 13.1.5 Medtronic Latest Developments
- 13.2 Abbott
- 13.2.1 Abbott Company Information
- 13.2.2 Abbott Implantable Neuromodulation Device Product Offered
- 13.2.3 Abbott Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Abbott Main Business Overview
- 13.2.5 Abbott Latest Developments
- 13.3 Boston Scientific Corporation
- 13.3.1 Boston Scientific Corporation Company Information
- 13.3.2 Boston Scientific Corporation Implantable Neuromodulation Device Product Offered
- 13.3.3 Boston Scientific Corporation Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Boston Scientific Corporation Main Business Overview
- 13.3.5 Boston Scientific Corporation Latest Developments
- 13.4 St. Jude Medical
- 13.4.1 St. Jude Medical Company Information
- 13.4.2 St. Jude Medical Implantable Neuromodulation Device Product Offered
- 13.4.3 St. Jude Medical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 St. Jude Medical Main Business Overview
- 13.4.5 St. Jude Medical Latest Developments
- 13.5 Synapse Biomedical
- 13.5.1 Synapse Biomedical Company Information
- 13.5.2 Synapse Biomedical Implantable Neuromodulation Device Product Offered
- 13.5.3 Synapse Biomedical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Synapse Biomedical Main Business Overview
- 13.5.5 Synapse Biomedical Latest Developments
- 13.6 Nevro Corporation
- 13.6.1 Nevro Corporation Company Information
- 13.6.2 Nevro Corporation Implantable Neuromodulation Device Product Offered
- 13.6.3 Nevro Corporation Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Nevro Corporation Main Business Overview
- 13.6.5 Nevro Corporation Latest Developments
- 13.7 Neuropace
- 13.7.1 Neuropace Company Information
- 13.7.2 Neuropace Implantable Neuromodulation Device Product Offered
- 13.7.3 Neuropace Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Neuropace Main Business Overview
- 13.7.5 Neuropace Latest Developments
- 13.8 Cyberonics
- 13.8.1 Cyberonics Company Information
- 13.8.2 Cyberonics Implantable Neuromodulation Device Product Offered
- 13.8.3 Cyberonics Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Cyberonics Main Business Overview
- 13.8.5 Cyberonics Latest Developments
- 13.9 Autonomic Technologies
- 13.9.1 Autonomic Technologies Company Information
- 13.9.2 Autonomic Technologies Implantable Neuromodulation Device Product Offered
- 13.9.3 Autonomic Technologies Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Autonomic Technologies Main Business Overview
- 13.9.5 Autonomic Technologies Latest Developments
- 13.10 Avery Biomedical
- 13.10.1 Avery Biomedical Company Information
- 13.10.2 Avery Biomedical Implantable Neuromodulation Device Product Offered
- 13.10.3 Avery Biomedical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Avery Biomedical Main Business Overview
- 13.10.5 Avery Biomedical Latest Developments
- 13.11 Greatbatch Medical
- 13.11.1 Greatbatch Medical Company Information
- 13.11.2 Greatbatch Medical Implantable Neuromodulation Device Product Offered
- 13.11.3 Greatbatch Medical Implantable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Greatbatch Medical Main Business Overview
- 13.11.5 Greatbatch Medical Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Implantable Neuromodulation Device. Industry analysis & Market Report on Implantable Neuromodulation Device is a syndicated market report, published as Global Implantable Neuromodulation Device Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Implantable Neuromodulation Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
